Professional Documents
Culture Documents
Cancer Relapse
Makkai-Popa, S.-T.1,2, Zugun, F.3, Georgescu, St.-O.1,2, Popa, Paula2, Carasevici, E.1,3, Tarcoveanu, E.1,2
1Gr.
T. Popa University of Medicine and Pharmacy Iasi, 2Sf. Spiridon University Hospital First Surgical Clinic, 3Sf. Spiridon University Hospital
Genetics and Immunology Laboratory
Introduction
Colorectal cancer incidence in Romania 23,57 cases
/ 100000 people. (Trifan et al, 2006)
Most commonly used prognostic classification TNM
staging correlated with the tumor grading;
New prognostic markers:
Lymph node based ratios:
Ratio between lymph nodes containing
metastases and the total number of resected
lymph nodes Sun et al, 2010, Jung Wook Huh
et al, 2012;
Logodds ratio Wang et al, 2008; Persiani et al,
2012;
Systemic markers:
Systemic inflammation Glasgow prognostic
score -McMillan et al, 2007; Roxburgh et al, 2009;
Serum level of tumor markers - CEA Jung
Wook Huh et al, 2012;
Results
39 patients 14 metastases (35,9%), 25 loco-regional
relapses (64,1%);
Gender distribution 17 (43,6%) males and 22
(56,4%) females, respectively 12 (48%) males and 13
(52%) females in the group of patients selected for
multivariate analysis;
Age distribution between 31 and 83 years old, with a
mean of 62,28 years, a standard deviation of 14,45
years and a median of 66 years;
Site of primary tumor 9(23,07%) right colon tumors
(caecum, ascending and transverse colon) 17(43,6%)
left colon tumors (descending colon and sigma)
13(33,3%) rectal tumors (including recto-sigmoid
tumors);
12(30,76%) cases presented as emergencies;
Poster template by ResearchPosters.co.za
Clinical characteristics
and theirLayout
correlation with
Altering The Column
the relapse prognosis
Number Number
of
of
invaded harvested
lymph
lymph
nodes
nodes
Type of relapse
Locoregional
relapse
Metastasis
Gender
Age
Location of primary
tumor
Emergency character
of first admission
Male
6 (54,5%)
5 (35,7%)
Female
5(45,5%)
9(64,3%)
<66
5(45,5%)
7(50%)
66
6(54,5%)
7(50%)
Right colon
1(9,1%)
5(35,7%)
Left colon
7(63,6%)
4(28,6%)
Rectum
3(27,3%)
5(35,7%)
Emergency
4(36,4%)
4(28,6%)
Elective
7(63,6%)
10(71,4%)
Chipsquare value
0,887
0,346
0,051
0.821
3,678
0,159
0,172
0,678
Tumor size
Resection margins
Presence of a
perforated tumor
Infiltration of serosal
layer
< 50 mm
50 mm
30 mm
> 30 mm
Yes
No
Not infiltrated
Type of relapse
LocoMetastasis
regional
relapse
2 (18,2%)
5 (35,7%)
9(81,8%)
9(64,3%)
4(36,4%)
6(42,9%)
7(63,6%)
8(57,1%)
2(18,2%)
2(14,3%)
9(81,8%)
7(85,7%)
3(27,3%)
2(14,3%)
Infiltrated
8(72,7%)
12(85,7%)
Well differentiated
Moderately
differentiated
1(9,1%)
4(28,6%)
9(81,8%)
8(57,1%)
Poorly differentiated
1(9,1%)
2(14,3%)
Yes
4(36,4%)
4(28,6%)
No
7(63,6%)
10(71,4%)
Presence of perineural
invasion
Yes
2(18,2%)
3(21,4%)
No
9(81,8%)
11(78,6%)
Presence of
intravascular tumor
emboli
Yes
6(54,5%)
3(21,4%)
Degree of tumor
differentiation
Presence of a mucinous
component
Degree of necrosis
No
5(45,5%)
11(78,6%)
Abundant
5(45,5%)
10(71,4%)
Rare
6(54,5%)
4(28,6%)
Lymph node
ratio (LNR)
Logodds
ratio
(LODDS)
Logodds
ratio for
patients
with 12
harvested
lymph
nodes
(LODDS12)
LNR
categories
defined by
quartiles
(LNR
quartiles)
Logodds
ratio
categories
defined by
quartiles
(LODDS
quartiles)
LNR
LODDS LODDS12
LNR
quartiles
LODDS
quartiles
rho
,945
-0,247
,938
,990
,949
,899
p-value
<0,001
0,235
<0,001
<0,001
<0,001
<0,001
rho
,872
-,498*
,938
,898
,961
p-value
<0,001
0,011
<0,001
<0,001
<0,001
rho
,951
-0,517
,990
,847
,917
p-value
<0,001
0,07
<0,001
<0,001
<0,001
rho
,848
-0,315
,949
,898
,847
,892
p-value
<0,001
0,126
<0,001
<0,001
<0,001
<0,001
rho
,785
-,579
,899
,961
,917
,892
p-value
<0,001
0,002
<0,001
<0,001
<0,001
<0,001
Table 4. Correlation of different lymph node ratios with the number of invaded lymph
nodes, with the number of harvested lymph nodes and between different coefficients .
pvalue
p-value = 0,021.
0,332
0,742
0,792
0,623
p-value = 0,049.
0,395
0,678
0,840
0,087
0,188
Spearman`s
rho
pvalue
-0,197
0,346
0,514
0,009
Perforated tumor
0,136
0,516
Stenotic tumor
0,055
0,792
0,023
0,914
Resection margin
-0,111
0,599
Infiltrated serosa
0,069
0,742
Inflammation
0,044
0,833
Acute inflammation
0,123
0,558
Chronic inflammation
-0,085
0,685
-0,104
0,621
Tumor differentiation
0,309
0,133
Tumor grading
0,208
0,318
0,166
0,426
0,305
0,138
0,035
0,869
0,238
0,252
SE
Wald
df
p-value
Exp(B)
0,906
-2,235
-0,898
0,73
0,82
1,1
1,53
7,32
0,62
1
1
1
0,216
0,007
0,431
2,47
0,10
0,40
-0,903
1,05
0,73
0,391
0,40
0,052
3,187
-0,006
-2,196
0,002
-0,087
5,526
1,01
0,82
0,01
0,04
1,80
0
7,13
0,03
4,71
9,33
1
1
1
1
1
0,995
0,008
0,856
0,03
0,002
0,99
0,11
1,00
0,91
251,11
0,137
0,022
0,982
0,847
7,257
7,204
0,557
1,022
0,992
8689,516
14,55
0,002
0,001
253824,5
5,252
2,17
5,85
0,016
190,97
2,715
13432,481
3,563
1,67
4,54
0,033
35,26
1,332
933,749
159,93 402836977,7
Table 5. Cox regression model for Logodds ratio and Logodds ratio categories after
allowing for the effects of other significant variables.
Conclusions
Small number of patients short time interval and
selection criteria further large scale studies are
necessary;
None of the pathology related factors could be
correlated to the type of relapse at a statistical
significance level of 0,05 or under;
Logodds ratio correlates well with all other lymph node
based scores, with the number of positive lymph nodes
(p<0,001) and with the number of harvested lymph
nodes (p=0,011, when Logodds is treated as a
continuous variable), whereas LNR only correlates
with the number of positive nodes (p<0,001), but not
with the total number of harvested nodes (p= 0,235);
Logodds could be used to stratify patients in terms of
relapse free survival time as shown by the KaplanMeier survival analysis;
In a Cox proportional hazard model we show that
Logodds ratio (p=0,002) togheter with the presence of
a mucionous component (p=0,008) can be used to
asses the aggressivness of the tumor in terms of how
fast a relapse can occur;